Gene expression signatures affected by alcohol-induced DNA methylomic deregulation in human embryonic stem cells.
- Authors
- Khalid, Omar; Kim, Jeffrey J; Kim, Hyun-Sung; Hoang, Michael; Tu, Thanh G; Elie, Omid; Lee, Connie; Vu, Catherine; Horvath, Steve; Spigelman, Igor; Kim, Yong
- Year
- 2014
- Journal
- Stem cell research
- PMID
- 24751885
- DOI
- 10.1016/j.scr.2014.03.009
- PMCID
- PMC4041389
Stem cells, especially human embryonic stem cells (hESCs), are useful models to study molecular mechanisms of human disorders that originate during gestation. Alcohol (ethanol, EtOH) consumption during pregnancy causes a variety of prenatal and postnatal disorders collectively referred to as fetal alcohol spectrum disorders (FASDs). To better understand the molecular events leading to FASDs, we performed a genome-wide analysis of EtOH's effects on the maintenance and differentiation of hESCs in culture. Gene Co-expression Network Analysis showed significant alterations in gene profiles of EtOH-treated differentiated or undifferentiated hESCs, particularly those associated with molecular pathways for metabolic processes, oxidative stress, and neuronal properties of stem cells. A genome-wide DNA methylome analysis revealed widespread EtOH-induced alterations with significant hypermethylation of many regions of chromosomes. Undifferentiated hESCs were more vulnerable to EtOH's effect than their differentiated counterparts, with methylation on the promoter regions of chromosomes 2, 16 and 18 in undifferentiated hESCs most affected by EtOH exposure. Combined transcriptomic and DNA methylomic analysis produced a list of differentiation-related genes dysregulated by EtOH-induced DNA methylation changes, which likely play a role in EtOH-induced decreases in hESC pluripotency. DNA sequence motif analysis of genes epigenetically altered by EtOH identified major motifs representing potential binding sites for transcription factors. These findings should help in deciphering the precise mechanisms of alcohol-induced teratogenesis.
Transcriptomic profiling of gene signatures in EtOH-treated or differentiating hESCs(A) WGCNA consensus cluster analysis of hESC genes comparing EtOH (20 mM) treatment of hESCs in their undifferentiated or EB states, as well as comparing undifferentiated and differentiated hESCs without EtOH treatment. Correlations of each respective comparison are shown below the module cluster. (B) EtOH dose-response (at 0, 20 and 50 mM) comparison between H1 and H9 cell lines using heatmaps of representative modules. We selected three representative modules that showed the same pattern of expression changes after EtOH treatment in both H1 and H9 hESCs. This is to demonstrate an example of EtOH-induced alterations in gene signatures independent of cell lines. (C) Cluster of the different modules in relation to differentiation and EtOH treatment. Turquoise and light-yellow modules that showed consistent gene expression correlations are indicated by asterisks. (D) A Volcano plot identified the number of the most significantly altered genes upon EtOH treatment between H1 and H9. (E) The top fourteen modules significantly affected by EtOH were analyzed by R package cluster Profiler and the resulted showed that the modules formed distinct ontological clusters without any overlap. (F) Molecular pathway analysis using KEGG database showed the dot plot of the gene ontology unique to each module of the most affected clusters in (E). Fisher Exact test was adopted to measure the gene-enrichment in annotation terms. When members of two independent groups can fall into one of two mutually exclusive categories, Fisher Exact test was used to determine whether the proportions of those falling into each category differ by group (Huang da et al., 2009). (G) Hive plot of the gene network associated with the turquoise consensus module. Red dots showed two top hub genes- SCUBE3 and SLC22A5. (H) Standard gene network representing the turquoise module. (I) The top hub genes, SCUBE3 and SLC22A5, and implicated genes based on maximal clique centrality.
Global DNA methylation changes at the transcription start site (TSS) and CpG islands (CGIs) upon EtOH treatment(A) EtOH increases DNA methylation in undifferentiated hESCs as measured by changes in % of 5-methylcytosine (5-mC). *, p < 0.05 versus 0 mM EtOH (one-way ANOVA). (B) DNA methylation changes after EtOH treatment in undifferentiated hESCs were assessed. Relative DNA methylation levels at the TSS (2.5 kb upstream and downstream) after treatment with 20 mM EtOH were plotted (left). It shows the status of DNA hypermethylation at the TSS resulted from EtOH treatment. Aligned probes plot of methylation showed that treatment of undifferentiated hESCs with 20 mM EtOH resulted in an increase in DNA methylation at the TSS compared to non-treated control (Middle). The Log plot for methylation at the TSS comparing control cells (x-axis) vs. cells treated with 20 mM EtOH (y-axis) showed greater level of DNA methylation after EtOH treatment (right). (C) DNA methylation changes at CGIs after EtOH treatment were assessed as described in (B). Relative DNA methylation plot at the CGIs after treatment with 20 mM EtOH showed an increase in DNA methylation on the DNA sequences upstream of CGIs (left). Aligned probes plot of methylation showed that treatment with 20 mM EtOH resulted in an increase in DNA methylation at the CGIs compared to non-treated control (Middle). The Log plot for methylation at the CGIs comparing control cells (x-axis) vs. cells treated with 20 mM EtOH (y-axis) showed greater level of DNA methylation after EtOH treatment (right).
EtOH-induced increases in DNA methylation in undifferentiated hESCs but not in embryoid bodies (EBs)Comparisons of average relative DNA methylation levels between (A) promoters of genes and (B) CpG islands of genes from undifferentiated hESCs (top panels) and hESC EBs (middle panels) treated with 0 mM or 20 mM EtOH. Bottom panel shows fold changes in DNA methylation for promoters and CpG islands of genes in EtOH-treated undifferentiated hESCs (blue bars) and EBs (red bars). Statistical analysis revealed that the EtOH-induced increases in methylation status of Promoter regions (and to a lesser extent CpG islands) were significantly different (p < 0.05, unpaired t-test) for undifferentiated hESCs vs. EBs at all 23 chromosomes.
Methylation vs. gene expression in EtOH-treated hESCsMethylation vs. gene expression of promoter regions during: (A) differentiation of hESCs, (B) EtOH treatment of undifferentiated hESCs and (C) EtOH treatment of EBs. Methylation vs. gene expression of CpG islands during: (D) differentiation of hESCs, (E) EtOH treatment of undifferentiated hESCs, and (F) EtOH treatment of EBs. (G) Summary of hyper and hypo methylated regions and their correlation to expression. (H) Rescue of genes downregulated by EtOH treatment after treatment with 5-azacytidine (5-Aza). Level of ACADY4, FGF17, HOXA1 and PHOSPHO1 gene was quantitatively assessed by qRT-PCR analysis with, without EtOH (20 mM), or after co- treatment with 20 mM EtOH and 1 μM of 5-Aza for 24 hrs. *, p < 0.05 vs. control; **, p < 0.05 vs. EtOH treatment (one-way ANOVA with Tukey's post hoc). (I) The level of hypo and hypermethylation at 2.5 kb upstream and downstream of the transcription start site (TSS) in EtOH-treated undifferentiated hESCs as shown in (B). The genes represent inverse correlation between methylation and expression- hypermethylated and downregulated (gold) vs. hypomethylated and upregulated (green). (J) A graph representing the average methylation found in I (green represents hypomethylated genes and gold represents hypermethylated genes). (K) Pie chart representing the level of hypo- and hypermethylation in genes both positively and negatively regulated. It shows how much hypo- or hypermethylation refers to either a decreased (negative) or increased (positive) gene expression.
Profiling of molecular signatures specifically affected by EtOH-induced DNA methylation in hESCsTo obtain a list of genes that are epigenetically altered by EtOH-induced DNA methylation changes, genes showing correlative changes in DNA methylation and in gene expression were identified. Genes showing β>0.5 in DNA methylation either on CpG islands or promoter regions with >2-fold change in gene expression were chosen from Fig. 4. Comparison was done to examine the effect of EtOH on the differentiation of hESCs. By combining the list of genes differentially regulated during hESC differentiation and the list of genes dysregulated by EtOH treatment in undifferentiated hESCs, we were able to identify genes that are potentially involved in the differentiation of hESC by EtOH-induced DNA methylation changes (common genes).
Quantitative RT-PCR validation of gene listThe expression levels of part of genes list obtained from Fig. 5 were validated. hESCs were treated with 0, 20, or 50 mM EtOH for 24 hrs and qRT-PCR performed as described in Materials and Methods. (A) Genes that were upregulated by EtOH-induced DNA hypomethylation. Note significantly increased expression in 3 of 8 genes, with none significantly decreased. (B) Genes that were downregulated by EtOH-induced hypermethylation. Note significantly decreased expression in 4 of 8 genes, with none significantly increased. Bars are mean ± SEM from triplicates; *, p < 0.05 vs. control; †, p < 0.05 vs. 20 mM EtOH (one-way ANOVA with Tukey post hoc).
Common motif analysis and EtOH-related transcription factor discoveryGenes that are affected by normal differentiation are shown in purple Venn diagrams (Up_Diff: Hypomethylated and upregulated during differentiation; Down_Diff: Hypermethylated and downregulated during differentiation). Genes that are significantly affected by EtOH are shown in yellow Venn diagrams (Up_EtOH: Hypomethylated and upregulated upon EtOH treatment; Down_EtOH: Hypermethylated and downregulated upon EtOH treatment). Subsets of genes that are affected by both EtOH and differentiation are shown in the middle. These genes are also represented in the middle orange box of Figure 5. Selected genes were further subjected to STAMP analysis to identify potential cis-regulatory elements that are present in the differentially regulated genes and transcription factors that could be potentially affected by EtOH treatment. Based on the common gene lists, common motifs and associated transcriptional factors are found for CpG and promoter respectively. E-value is calculated based on the Wasserman and Sandelin method (Wasserman and Sandelin, 2004).
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Effects of alcohol on the transcriptome, methylome and metabolome of in vitro gastrulating human embryonic cells. | Wallén E et al. | — | 2025 | → |
| Metabolism-epigenetic interaction-based bone and dental regeneration: From impacts and mechanisms to treatment potential. | Chen X et al. | — | 2025 | → |
| Nonconceptus Mechanisms of Prenatal Alcohol Exposure That Disrupt Embryo-Fetal Development: An Integrative View. | Smith SM | — | 2025 | → |
| Physiologic and molecular effects of alcohol in the esophagus: a narrative review. | Shaker A | — | 2025 | → |
| Oxidative Effects in Early Stages of Embryo Development Due to Alcohol Consumption. | González-Flores D et al. | — | 2024 | → |
| Epigenetics in fetal alcohol spectrum disorder. | Basavarajappa BS | — | 2023 | → |
| Ethanol exposure perturbs sea urchin development and disrupts developmental timing. | Rodríguez-Sastre N et al. | — | 2023 | → |
| Is 'a little' too much?: An exploration of women's beliefs about alcohol use during pregnancy. | Fletcher TMD et al. | — | 2023 | → |
| Chromatin modifier developmental pluripotency associated factor 4 (DPPA4) is a candidate gene for alcohol-induced developmental disorders. | Auvinen P et al. | — | 2022 | → |
| Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: a position paper from the EU-CardioRNA COST action CA17129. | Vanhaverbeke M et al. | — | 2022 | → |
| The Impact of Oxidative Stress on Pediatrics Syndromes. | Micangeli G et al. | — | 2022 | → |
| Biochemical Mechanisms Associating Alcohol Use Disorders with Cancers. | Rodriguez FD et al. | — | 2021 | → |
| DNA methylation differences associated with social anxiety disorder and early life adversity. | Wiegand A et al. | — | 2021 | → |
| Epigenetic Impacts of Early Life Stress in Fetal Alcohol Spectrum Disorders Shape the Neurodevelopmental Continuum. | Alberry B et al. | — | 2021 | → |
| Intersection of Epigenetic and Immune Alterations: Implications for Fetal Alcohol Spectrum Disorder and Mental Health. | Lussier AA et al. | — | 2021 | → |
| The Effects of Early Prenatal Alcohol Exposure on Epigenome and Embryonic Development. | Wallén E et al. | — | 2021 | → |
| Fetal alcohol spectrum disorders: Genetic and epigenetic mechanisms. | Kaminen-Ahola N | — | 2020 | → |
| Hippocampal transcriptome analysis following maternal separation implicates altered RNA processing in a mouse model of fetal alcohol spectrum disorder. | Alberry BLJ et al. | — | 2020 | → |
| Long-term spatial tracking of cells affected by environmental insults. | Mohammad S et al. | — | 2020 | → |
| Modification of stem cell states by alcohol and acetaldehyde. | Serio RN et al. | — | 2020 | → |
| Molecular consequences of fetal alcohol exposure on amniotic exosomal miRNAs with functional implications for stem cell potency and differentiation. | Tavanasefat H et al. | — | 2020 | → |
| Smoke, alcohol and drug addiction and female fertility. | de Angelis C et al. | — | 2020 | → |
| Alcohol Use in Pregnancy. | Dejong K et al. | — | 2019 | → |
| Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity. | Apáti Á et al. | — | 2019 | → |
| Hippocampal transcriptome analysis following maternal separation implicates altered RNA processing in a mouse model of fetal alcohol spectrum disorder | Alberry BL et al. | — | 2019 | — |
| Hippocampal transcriptome reveals novel targets of FASD pathogenesis. | Lunde-Young R et al. | — | 2019 | → |
| Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cells. | Di Rocco G et al. | — | 2019 | → |
| Alcohol exposure promotes DNA methyltransferase DNMT3A upregulation through reactive oxygen species-dependent mechanisms. | Miozzo F et al. | — | 2018 | → |
| Detrimental effects of alcohol exposure around conception: putative mechanisms. | Kalisch-Smith JI et al. | — | 2018 | → |
| Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression. | Zhang J et al. | — | 2018 | → |
| Maternal alcohol consumption and offspring DNA methylation: findings from six general population-based birth cohorts. | Sharp GC et al. | — | 2018 | → |
| PAX9 regulates squamous cell differentiation and carcinogenesis in the oro-oesophageal epithelium. | Xiong Z et al. | — | 2018 | → |
| Pluripotent Stem Cells in Developmental Toxicity Testing: A Review of Methodological Advances. | Luz AL et al. | — | 2018 | → |
| Selective inhibition of CTCF binding by iAs directs TET-mediated reprogramming of 5-hydroxymethylation patterns in iAs-transformed cells. | Rea M et al. | — | 2018 | → |
| The impact of epigenomic next-generation sequencing approaches on our understanding of neuropsychiatric disorders. | Schang AL et al. | — | 2018 | → |
| Alcohol and Cancer Stem Cells. | Xu M et al. | — | 2017 | → |
| Epigenetics studies of fetal alcohol spectrum disorder: where are we now? | Lussier AA et al. | — | 2017 | → |
| Fetal Alcohol Exposure: The Common Toll. | Nakhoul MR et al. | — | 2017 | → |
| Gestational Alcohol Exposure Altered DNA Methylation Status in the Developing Fetus. | Mandal C et al. | — | 2017 | → |
| Involvement of Wnt pathway in ethanol-induced inhibition of mouse embryonic stem cell differentiation. | Wang Q et al. | — | 2017 | → |
| Modulation of Neocortical Development by Early Neuronal Activity: Physiology and Pathophysiology. | Kirischuk S et al. | — | 2017 | → |
| Review: DNA methylation and alcohol use disorders: Progress and challenges. | Zhang H et al. | — | 2017 | → |
| Alcohol-Induced Molecular Dysregulation in Human Embryonic Stem Cell-Derived Neural Precursor Cells. | Kim YY et al. | — | 2016 | → |
| Alcohol-induced suppression of KDM6B dysregulates the mineralization potential in dental pulp stem cells. | Hoang M et al. | — | 2016 | → |
| Bioinformatic Analysis of DNA Methylation in Neural Progenitor Cell Models of Alcohol Abuse. | Oni EN et al. | — | 2016 | → |
| Epigenetic Mechanisms in Developmental Alcohol-Induced Neurobehavioral Deficits. | Basavarajappa BS et al. | — | 2016 | → |
| Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease. | Anstee QM et al. | — | 2016 | → |
| Homocysteine, Alcoholism, and Its Potential Epigenetic Mechanism. | Kamat PK et al. | — | 2016 | → |
| Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I. | Khalid O et al. | — | 2016 | → |
| Regulation at multiple levels control the expression of folate transporters in liver cells in conditions of ethanol exposure and folate deficiency. | Thakur S et al. | — | 2015 | → |
| Time- and dose-dependent effects of ethanol on mouse embryonic stem cells. | Worley SL et al. | — | 2015 | → |